Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, inclu...
Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program | SILO Stock News
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform | SILO Stock News
Silo Pharma Raises Approximately $3.5 Million Net in Private Placement; Grants Resale Rights
Silo Pharma shares are trading lower after the company announced a $11.7 million private placement of 619,965 shares at $6.452 per share with warrants exercisable at $6.21 per share.
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Pre-Market Session